PGY-2 Oncology Residency - Adults

PGY-2 Oncology Residency - Adults


The Pharmacy Department at Memorial Sloan Kettering recognizes the value and need for an oncology specialty residency for pharmacists seeking a career in oncology practice.


PGY2 pharmacy residency training builds on the foundations of pharmacy practice established during Doctor of Pharmacy (Pharm.D.) education and the PGY1 pharmacy residency experience. The MSKCC PGY2 oncology residency provides residents with a 12 month learning experience that prepares them to function independently as a clinical pharmacy practitioner in oncology, to serve as a fully integrated member of a multi-disciplinary team, and to optimize medications used in the provision of cancer care. Residents who successfully complete a PGY2 oncology pharmacy residency at MSKCC will possess competencies that prepare them for future clinical, research or academic positions, leadership roles in oncology, and board certification in oncology pharmacy.

The Adult Oncology Specialty Residency provides advanced training in clinical therapeutics for the adult cancer patient. The main goals of this residency are to:

  1. Develop and build the knowledge and clinical skills required to practice as an independent oncology practitioner.
  2. Emphasize the role of Continuous Professional Development (CPD) through literature evaluation, didactic lectures, roundtable discussions, self learning, and continuous self reflection.
  3. Apply evidence-based guidelines and standards in tailoring the treatment plan to maximize patient care and outcomes.

Required Rotations

  • Orientation
  • Leukemia: Inpatient
  • Lymphoma: Inpatient
  • Bone Marrow Transplant: Inpatient
  • Multiple Myeloma: Inpatient and Outpatient
  • Cellular Therapy Service: Inpatient and Outpatient
  • Neuro-oncology: Inpatient and Outpatient
  • Gastrointestinal Malignancies: Outpatient 
  • Gynecologic Malignancies: Outpatient
  • Genitourinary Malignancies: Outpatient
  • Breast Cancer: Outpatient
  • Pediatrics: Inpatient
  • Infectious Diseases: Inpatient
  • Research Month
  • Early Drug Development: Outpatient
  • Thoracic Malignancies: Inpatient and Outpatient
  • Melanoma: Outpatient
  • Investigational Drug Services

Elective Rotations

During the year, two weeks of rotation are chosen as electives based on resident preference. They may choose to repeat rotations from prior experience or choose to complete one of the following elective offerings:

  • Pain and Palliative Care
  • Leukemia clinic
  • Lymphoma clinic
  • BMT clinic

Application Deadline

January 2, 2024

Length of Program

One year

Number of Positions

Two to Four


  • Successful completion of an ACPE accredited Doctor of Pharmacy program
  • Successful completion of an ASHP accredited PGY-1 Pharmacy Practice Residency
  • Eligibility for pharmacist licensure in New York State (Residents are required to obtain Pharmacist licensure in the State of New York)
  • Interview in the Personal Placement Service (PPS) at ASHP Midyear Clinical Meeting

How to Apply

Interested candidates should submit the following through Pharmacy Online Residency Centralized Application (PhORCAS):

  • Letter of interest explaining career goals
  • Three letters of recommendation (standard PHORCAS format)
  • Academic transcript
  • Curriculum Vitae

Additional Information

Frequently Asked Questions  
Past Residents  
Residency Program Preceptors  
Residency Learning Experiences and Teaching Activities


Lisa Modelevsky, PharmD, BCOP
Manager, Clinical Pharmacy Services
Adult Oncology PGY-2 Residency Program Director
Memorial Sloan Kettering Cancer Center
460 E. 63rd St. 
New York, NY 10065
[email protected]